Robert A. Stockley
University Hospital Birmingham NHS Foundation Trust
Birmingham
UK
Name/email consistency: high
- Progression of chronic obstructive pulmonary disease: impact of inflammation, comorbidities and therapeutic intervention. Stockley, R.A. Curr. Med. Res. Opin (2009)
- Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development. Stockley, R.A., Luisetti, M., Miravitlles, M., Piitulainen, E., Fernandez, P. Eur. Respir. J. (2007)
- Addition of salmeterol to existing treatment in patients with COPD: a 12 month study. Stockley, R.A., Chopra, N., Rice, L. Thorax (2006)
- Improved outcomes in patients with chronic obstructive pulmonary disease treated with salmeterol compared with placebo/usual therapy: results of a meta-analysis. Stockley, R.A., Whitehead, P.J., Williams, M.K. Respir. Res. (2006)
- Neutrophils and the pathogenesis of COPD. Stockley, R.A. Chest (2002)
- The effect of augmentation therapy on bronchial inflammation in alpha1-antitrypsin deficiency. Stockley, R.A., Bayley, D.L., Unsal, I., Dowson, L.J. Am. J. Respir. Crit. Care Med. (2002)
- Assessment of airway neutrophils by sputum colour: correlation with airways inflammation. Stockley, R.A., Bayley, D., Hill, S.L., Hill, A.T., Crooks, S., Campbell, E.J. Thorax (2001)
- Alpha-1-antitrypsin deficiency: what next?. Stockley, R.A. Thorax (2000)